Telemedicine

Teladoc Health Launches Telemedicine Service in Canada, Expanding Portfolio of Available Healthcare Solutions. Canadians to benefit from access to anytime, anywhere high-quality physician care

TORONTO, ON, March 28, 2019 –Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today the launch of Teladoc Telemedicine Services, the first-of-its-kind offering to provide Canadians with 24×7 access to convenient, high-quality medical care regardless of their location across the country or in the U.S. The new service addresses head-on the healthcare access issues Canadians are facing in terms of overcrowded emergency rooms, physician shortages, and long wait times, which have been persistent in rural and urban areas alike. It also supports efforts of employers to address illness-related productivity issues… READ MORE

double exposure image of virtual human 3dillustration on blue circuit board background represent artificial 
intelligence AI technology

Cardinal Analytx Bounds into Next Growth Phase with Former DecisionView CEO Linda Hand at Helm

Cardinal Analytx Solutions, a developer of advanced machine learning solutions for improving healthcare while reducing costs by predicting impending medical conditions, today announced it has hired healthcare veteran Linda T. Hand as CEO to lead the company through its next phase of growth. Formerly president and CEO of DecisionView, Hand joins Cardinal Analytx at a pivotal time of significant company momentum, with two new advisors also coming aboard….  READ MORE

vitals

Vitals Announces Company Name Change to Sapphire Digital

FEBRUARY 20, 2019 – LYNDHURST, N.J. – Vitals announces that we are changing our name to Sapphire Digital. The new name reflects our leadership in providing a full omnichannel digital engagement and shopping platform for consumers, employers and health plans to impact the cycle of high-cost health care…. READ MORE

abide

Abide Continues Support of the Tourette Community Through Collaboration with Tourette Association of America

Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, announced about its continuation of collaboration with the Tourette Association of America (TAA) that began in 2017;  Abide Therapeutics has renewed its commitment to partnering with the TAA to gain a better understanding of the unmet needs in the Tourette community… READ MORE

Scroll to top